Winners were:

• Family Health International, for their best practices (2 awards):
  • Research Ethics Training Curriculum
  • Ethics Training Curriculum for Community Representatives
• National Institutes of Health, Department of Clinical Bioethics, for their innovation, Framework and Benchmarks for Evaluation of Research
• Partners Healthcare System, for their best practice, Human Research Quality Improvement Program.
• Washington University, School of Medicine and Human Studies, for their best practice, St. Louis IRB Consortium.

Awards are given for demonstrated excellence in promoting the well being of people who participate in research. The Health Improvement Institute created this awards program. The Office of Human Research Protection was the founding sponsor of the awards program. Sponsors of the 2005 awards program included American Diabetes Association and Pfizer. Judges and Committee and Award Advisory Board members are volunteers.

**********
Health Improvement Institute is a non-profit 501(c)3 charitable organization dedicated to improving the quality and productivity of America’s health care. The Institute conducts forums on emerging treatments and sponsors national awards recognizing excellence in health communications.

The Office for Human Research Protections (OHRP) – together with the federal Food and Drug Administration – oversees programs for the protections of human subjects at more than 4,000 HHS-funded universities, hospitals, and other medical and behavioral research institutions and private research sites in the United States and abroad.

American Diabetes Association is the nation's leading nonprofit health organization providing diabetes research, information and advocacy. Founded in 1940, the American Diabetes Association conducts programs in all 50 states and the District of Columbia, reaching hundreds of communities.

Pfizer Inc discovers, develops, manufactures and markets leading prescription medicines, for humans and animals, and many of the world’s best-known consumer brands. Pfizer Global Research and Development, the R&D division of Pfizer Inc, is the world’s largest privately funded biomedical research operation. With a 2003 budget of $7.1 billion and 15,000 researchers at sites around the world, Pfizer Global R&D has 400 potential new medicines in development for diseases including cancer, diabetes, heart disease and Alzheimer'’ disease.

**********
For information about the Award for Excellence in Human Research Protection, please contact the Awards Coordinator at 301-320-0971 or by email hii@hii.org.

To view details of Awards